A Randomized Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (Itraconazole)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00769600
Recruitment Status : Terminated (Low accrual.)
First Posted : October 9, 2008
Last Update Posted : October 14, 2016
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2013
  Actual Study Completion Date : February 2013

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 20, 2017
April 28, 2017
2 July 12, 2017
August 10, 2017
3 August 14, 2017
September 12, 2017
4 December 8, 2017
December 8, 2017
5 February 2, 2018
February 6, 2018